Form 4: Halozyme Therapeutics Director Connie Matsui Reports Gift of Shares

Director Connie Matsui of Halozyme Therapeutics reported a gift of 10,470 common stock shares to charity.

Summary

• Connie Matsui, a director at Halozyme Therapeutics, has reported a transaction involving the company's common stock.
• On November 29, 2024, Ms. Matsui gifted 10,470 shares of common stock to a charity.
• The transaction was a bona fide gift, and the shares were valued at $0 for the purpose of this filing.
• Following this transaction, Ms. Matsui directly owns 183,035 shares of Halozyme Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document is a routine filing of a stock gift, which is neither positive nor negative for the company's performance.

Industry Context

This is a routine filing for a director's transaction and does not indicate any significant trend in the biotechnology industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders, such as directors, to report changes in their beneficial ownership of company stock.
• The gift of shares to charity is a common practice and does not indicate any unusual activity compared to other similar filings by directors of publicly traded companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a gift of shares by a director and does not involve a sale on the open market.

Key Dates

Keywords

Halozyme Therapeutics, Connie Matsui, stock gift, Form 4, director, charity, share ownership